Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M85,592Revenue $M6,932Net Margin (%)27.8Z-Score18.2
Enterprise Value $M84,321EPS $7.8Operating Margin %38.4F-Score8
P/E(ttm))34.3Cash Flow Per Share $7.4Pre-tax Margin (%)38.2Higher ROA y-yY
Price/Book8.210-y EBITDA Growth Rate %25.7Quick Ratio1.9Cash flow > EarningsY
Price/Sales9.55-y EBITDA Growth Rate %20.1Current Ratio2.3Lower Leverage y-yY
Price/Cash Flow20.5y-y EBITDA Growth Rate %51.4ROA % (ttm)20.2Higher Current Ratio y-yY
Dividend Yield %0Insider Buy (3m)0ROE % (ttm)27.3Less Shares Outstanding y-yY
Payout Ratio %0Shares Outstanding M236ROI % (ttm)19.7Gross Margin Increase y-yN

Gurus Latest Trades with BIIB

Number of guru portfolios checked: 85. (List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
BIIBKen Heebner 2014-09-30 Buy 0.75%$299.29 - $346.3
($329.79)
$ 362.4410%New holding, 80000 sh.80,000
BIIBJoel Greenblatt 2014-09-30 Buy 0.1%$299.29 - $346.3
($329.79)
$ 362.4410%New holding, 31391 sh.31,391
BIIBRay Dalio 2014-09-30 Buy $299.29 - $346.3
($329.79)
$ 362.4410%New holding, 1646 sh.1,646
BIIBVanguard Health Care Fund 2014-09-30 Reduce-0.27%$299.29 - $346.3
($329.79)
$ 362.4410%Reduce -58.26%233,600
BIIBKen Fisher 2014-06-30 Add0.05%$274 - $320.13
($300.74)
$ 362.4420%Add 386.61%88,885
BIIBRon Baron 2014-06-30 Add$274 - $320.13
($300.74)
$ 362.4420%Add 41.76%8,632
BIIBKen Heebner 2014-06-30 Sold Out -0.95%$274 - $320.13
($300.74)
$ 362.4420%Sold Out0
BIIBAndreas Halvorsen 2014-06-30 Sold Out -0.5%$274 - $320.13
($300.74)
$ 362.4420%Sold Out0
BIIBJoel Greenblatt 2014-06-30 Sold Out -0.02%$274 - $320.13
($300.74)
$ 362.4420%Sold Out0
BIIBGeorge Soros 2014-06-30 Sold Out -0.02%$274 - $320.13
($300.74)
$ 362.4420%Sold Out0
BIIBJohn Burbank 2014-06-30 Sold Out -0.01%$274 - $320.13
($300.74)
$ 362.4420%Sold Out0
BIIBKen Heebner 2014-03-31 Buy 0.95%$273.518 - $351.94
($316.4)
$ 362.4415%New holding, 116000 sh.116,000
BIIBAndreas Halvorsen 2014-03-31 Buy 0.5%$273.518 - $351.94
($316.4)
$ 362.4415%New holding, 388900 sh.388,900
BIIBJoel Greenblatt 2014-03-31 Buy 0.02%$273.518 - $351.94
($316.4)
$ 362.4415%New holding, 3931 sh.3,931
BIIBGeorge Soros 2014-03-31 Buy 0.02%$273.518 - $351.94
($316.4)
$ 362.4415%New holding, 7500 sh.7,500
BIIBRon Baron 2014-03-31 Buy 0.01%$273.518 - $351.94
($316.4)
$ 362.4415%New holding, 6089 sh.6,089
BIIBJohn Burbank 2014-03-31 Buy 0.01%$273.518 - $351.94
($316.4)
$ 362.4415%New holding, 783 sh.783
BIIBKen Fisher 2014-03-31 Add0.01%$273.518 - $351.94
($315.54)
$ 362.4415%Add 796.27%18,266
BIIBVanguard Health Care Fund 2014-03-31 Reduce-0.24%$273.518 - $351.94
($315.54)
$ 362.4415%Reduce -32.19%599,400
BIIBRay Dalio 2014-03-31 Sold Out -0.04%$273.518 - $351.94
($316.4)
$ 362.4415%Sold Out0
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

BIIB is held by these Gurus:

Ticker Guru Name Portfolio Date* Current Shares % of Shares Outstanding % of Total Assets Managed Change from Last Holdings Holding History
BIIB Ken Heebner 2014-09-3080,0000.030.75New Buy
BIIB Joel Greenblatt 2014-09-3031,3910.010.1New Buy
BIIB Ray Dalio 2014-09-301,64600New Buy
BIIB Mario Gabelli 2014-09-304,63500.01+11.02%
BIIB Frank Sands 2014-09-304,952,0962.14.1+1.24%
BIIB Ron Baron 2014-09-308,61300.01-0.22%
BIIB PRIMECAP Management 2014-09-3017,216,6317.296.1-0.24%
BIIB Ken Fisher 2014-09-3078,4570.030.06-11.73%
BIIB Vanguard Health Care Fund 2014-09-30233,6000.10.2-58.26%
Premium Most recent portfolio changes are included for Premium Members only!


BIIB: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Artavanis-Tsakonas SpyridonSVP, Chief Scientific Officer 2014-12-15Sell1,981$346.54.6view
Sandrock AlfredGrp SVP, Chief Medical Officer 2014-12-04Sell440$345.884.79view
Holtzman Steven HEVP Corporate Development 2014-12-02Sell1,749$335.657.98view
Holtzman Steven HEVP Corporate Development 2014-11-11Sell1,750$3309.83view
SCANGOS GEORGE ACEO 2014-11-03Sell1,128$320.7812.99view
Holtzman Steven HEVP Corporate Development 2014-10-01Sell1,750$330.979.51view
SCANGOS GEORGE ACEO 2014-10-01Sell1,127$330.979.51view
SCANGOS GEORGE ACEO 2014-09-02Sell1,128$345.474.91view
SCANGOS GEORGE ACEO 2014-08-01Sell1,128$332.938.86view
SCANGOS GEORGE ACEO 2014-07-16Sell12,316$312.3716.03view

Press Releases about BIIB :

    Quarterly/Annual Reports about BIIB:

    News about BIIB:

    Articles On GuruFocus.com
    J.P. Morgan Chimes In With Ratings On BioTech Stocks Jan 06 2015 
    Pfizer Spreading Its Wings Into A New Domain Of Life Sciences Dec 09 2014 
    Biogen’s Alzheimer’s Drug Moves to Phase III Dec 03 2014 
    Gilead Sciences Releases Impressive Results for Hepatitis C Drug Nov 12 2014 
    Three Attractively Priced Small Cap Biotech Stocks Nov 05 2014 
    Ebola Diagnosis in U.S. Raises Pharmaceutical Stock by 20% Oct 01 2014 
    A Few Reasons Why AbbVie's Momentum Will Continue Sep 25 2014 
    Baxter Will Remain Diversified and With Competitive Advantages Sep 02 2014 
    Ken Fisher's Top Increaes of the Second Quarter Jul 28 2014 
    Ken Fisher's Top Increases of the First Quarter Apr 22 2014 

    More From Other Websites
    Google, Biogen Seek Reasons for Advance of Multiple Sclerosis Jan 27 2015
    Big Cap Stocks Mylan, American Tower Near Buy Points Jan 26 2015
    CORRECTING AND REPLACING Biogen Idec to Report Fourth Quarter and Year End 2014 Financial Results on... Jan 26 2015
    Biogen Idec Earnings: What to Watch Jan 26 2015
    CORRECTING AND REPLACING Biogen Idec to Report Fourth Quarter and Year End 2014 Financial Results on... Jan 26 2015
    Apple, Facebook Lead This Week's IBD 50 Earnings Jan 26 2015
    Apple, Facebook Lead Top IBD 50 Earnings This Week Jan 24 2015
    Lightning Round: These stocks bottomed last week Jan 23 2015
    /R E P E A T -- Corporate Knights announces 11th annual Global 100 index/ Jan 22 2015
    New Highs: Anheuser-Busch, Infosys Break Out Jan 21 2015
    Corporate Knights announces 11th annual Global 100 index Jan 21 2015
    Biotech Stock Roundup: EU Approvals for AbbVie & Celgene Drugs, CytRx Partial Clinical Hold Lifted -... Jan 21 2015
    Tuesday's Market Recap Jan 20 2015
    Great Humblers: (Jeez! We Shoulda Seen 'Em Coming) Jan 16 2015
    Nomura's Takeways From Biogen Idec's Analyst Meeting Jan 16 2015
    Isis Pharmaceuticals Earns Milestone Payment from Biogen - Analyst Blog Jan 15 2015
    Healthcare Executives on a Saturday Jan 15 2015
    Big Pharma faces up to new price pressure from aggressive insurers Jan 15 2015
    Insight - Big Pharma faces up to new price pressure from aggressive insurers Jan 15 2015
    Big Pharma faces up to new price pressure from aggressive insurers Jan 15 2015

    Add Notes, Comments

    If you want to ask a question, or report a bug, please create a support ticket.

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    Free 7-day Trial
    FEEDBACK